Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association of Biomarkers Detected by Optical Coherence Tomography Angiography (OCTA) of the Macula With Cognitive Functions in Patients With Type 2 Diabetes

NCT07135440 is registered in ClinicalTrials.gov with Dr. Sefic Eye Polylcinic and Optical Studio as lead sponsor.

NCT NCT07135440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association of Biomarkers Detected by Optical Coherence Tomography Angiography (OCTA) of the Macula With Cognitive Functions in Patients With Type 2 Diabetes
Lead sponsor
Dr. Sefic Eye Polylcinic and Optical Studio
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2024
Completion date
December 31, 2025
Enrollment
210 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus diabetic retinopathy cognitive dysfunction